Showing results (151-160 of 161) with videos related to
Sort By:
Pageof 17
Revue Des Maladies Respiratoires|December 31, 1997
[Lung volume reduction surgery in emphysema]M Fournier, G Lesèche, J Marty, et al.Seminars in Oncology|October 1, 1996
Carboplatin plus paclitaxel in the first-line treatment of advanced ovarian cancer: preliminary results of a phase I studyC Lhommé, P Kerbrat, C Lejeune, et al.Bone Reports|January 11, 2020
FGF21, not GCN2, influences bone morphology due to dietary protein restrictionsMargaret A McNulty, Brad A Goupil, Diana C Albarado, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 8, 2001
The integration of anthracyclines in the treatment of advanced ovarian cancerH J Lück, A Du Bois, B Weber, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 12, 2002
Multicentre phase II study of oxaliplatin as a single-agent in cisplatin/carboplatin +/- taxane-pretreated ovarian cancer patientsV Dieras, P Bougnoux, T Petit, et al.Presse Medicale (Paris, France : 1983)|April 13, 1996
[Pulmonary emphysema: surgical indications]H Mal, C Roué, C Sleiman, et al.Gynecologic Oncology|September 14, 2000
High-dose platinum versus standard dose in advanced ovarian carcinoma: a randomized trial from the Gynecologic Cooperative Group of the French Comprehensive Cancer Centers (FNCLCC)F Joly, J F Héron, P Kerbrat, et al.Lasers in Surgery and Medicine|January 1, 1983
Laser oncology in Italy: experimental research and clinical applications at the National Cancer Institute, MilanH Emanuelli, G Bandieramonte, R Marchesini, et al.Plos Neglected Tropical Diseases|April 9, 2020
Route of inoculation and mosquito vector exposure modulate dengue virus replication kinetics and immune responses in rhesus macaquesMichael K McCracken, Gregory D Gromowski, Lindsey S Garver, et al.European Journal of Gynaecological Oncology|August 15, 2001
Phase II study of a combination of cyclophosphamide, adriamycin and cisplatin in advanced fallopian tube carcinoma. An EORTC gynecological cancer group study. European Organization for Research and Treatment of CancerH C Wagenaar, S Pecorelli, I Vergote, et al.Pageof 17